Skandinaviska Enskilda Banken Ab (Publ) Tandem Diabetes Care Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$24.18 - $42.46 $100,903 - $177,185	-4,173 Reduced 3.41%	118,221 $2.9 Million
Q1 2023 May 11, 2023	SELL	$35.86 - $46.5 $7,207 - $9,346	-201 Reduced 0.16%	122,394 $4.97 Million
Q4 2022 Feb 08, 2023	SELL	$35.49 - $56.15 $2,200 - $3,481	-62 Reduced 0.05%	122,595 $5.51 Million
Q2 2022 Aug 10, 2022	BUY	$53.22 - $123.09 $1.33 Million - $3.08 Million	25,058 Added 25.67%	122,657 $7.26 Million
Q1 2022 May 11, 2022	BUY	$101.89 - $150.09 $80,900 - $119,171	794 Added 0.82%	97,599 $11.4 Million
Q4 2021 Feb 10, 2022	BUY	$118.18 - $153.21 $86,507 - $112,149	732 Added 0.76%	96,805 $14.7 Million
Q1 2021 May 14, 2021	BUY	$81.28 - $104.34 $7.81 Million - $10 Million	96,073 New	96,073 $8.48 Million

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.